+33 1 76 70 47 90 / creativ@creativ-ceutical.com

Bayesian Network Meta-Analysis (NMA) to Assess the Relative Efficacy of Canagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Insulin

Bayesian Network Meta-Analysis (NMA) to Assess the Relative Efficacy of Canagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Insulin

2015 Value Health

Taieb, V. | Pacou, M. | Schroeder, M. | Nielsen, A. T. | Neslusan, C. | Schubert, A. | Volume: 18, Issue: 7, Pages: A598,
https://www.doi.org/10.1016/j.jval.2015.09.2047